rxstat › Drug prices › Trastuzumab

Trastuzumab (Ogivri) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Trastuzumab 150 mg/vial powder for solution costs about $483.14 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Trastuzumab has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formAB
150 mg/vial Powder For Solution$483.14/unitnot covered
440 mg/vial Powder For Solution$1417.20/unitnot covered
600 mg/5ml Solutionper mL$525.00not covered
420 mg/vial Kit$1417.21/unitnot covered
Plan coverageNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 9 products
  • Ontruzant 150 mg/vial Powder For Solution · SSB
    DIN 02524317 · $483.14/unit · Not covered
  • Herzuma 150 mg/vial Powder For Solution · CHC
    DIN 02506211 · $506.14/unit · Not covered
  • Kanjinti 150 mg/vial Powder For Solution · AMG
    DIN 02518244 · $506.15/unit · Not covered
  • Ogivri 150 mg/vial Powder For Solution · BBC
    DIN 02474425 · $506.15/unit · Not covered
  • Herceptin Sc 600 mg/5ml Solution · HLR
    DIN 02480697 · $525.00/mL · Not covered
  • Herzuma 440 mg/vial Powder For Solution · CHH
    DIN 02480794 · $1417.20/unit · Not covered
  • Ontruzant 440 mg/vial Powder For Solution · SSB
    DIN 02524325 · $1417.20/unit · Not covered
  • Kanjinti 420 mg/vial Kit · AMG
    DIN 02496690 · $1417.21/unit · Not covered
  • Herceptin 440 mg/vial Powder For Solution · HLR
    DIN 02240692 · $2874.05/unit · Not covered

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

Resolved
OGIVRI
150MG · POWDER FOR SOLUTION · BGP PHARMA ULC
DIN 02474425 · ended Aug 13, 2020 · Delay in shipping of the drug.
Resolved
OGIVRI
150MG · POWDER FOR SOLUTION · BGP PHARMA ULC
DIN 02474425 · ended Jul 30, 2020 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Trastuzumab. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Trastuzumab is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XC).

Recent changes

Common questions

How much does Trastuzumab cost in Canada?

Trastuzumab 150 mg/vial powder for solution costs about $483.14 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. It is not a covered benefit on the public plans we track; the price shown is a list price.

Is Trastuzumab covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Trastuzumab be back in stock in Canada?

Trastuzumab has no active shortage; supply is normal per Health Canada reports.

Why is Trastuzumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other antineoplastic agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.